AMLX
Amylyx Pharmaceuticals Inc
30.10$
-1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -1,506.6% | – | |
| – | +0.0% | +5,100.0% | +836.5% | +123.4% | -16.9% | -41.9% | |
| – | +125.0% | +1,190.5% | +592.4% | +71.1% | -11.1% | -16.3% | |
| – | – | +184.4% | +155.9% | – | – | – | |
| – | -25.8% | +76.8% | -135.7% | – | – | – | |
| – | +0.0% | +133.8% | +615.6% | -50.9% | -87.3% | -12.1% | |
| – | +0.0% | +30,632.5% | +415.0% | – | -17.8% | -81.4% | |
| – | – | – | – | -100.8% | – | – | |
| – | +2,523.6% | +54.0% | -100.0% | – | – | – | |
| – | +6,909.4% | +238.5% | +172.4% | -99.2% | -90.2% | +73,758.9% | |
| – | +222.7% | +274.1% | -65.5% | +737.0% | -185.5% | – | |
| – | – | – | – | – | -1,671.5% | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.